Adrenal Tumors - Pathogenesis and Therapy
Information source: University of Wuerzburg
ClinicalTrials.gov processed this data on August 20, 2015 Link to the current ClinicalTrials.gov record.
Condition(s) targeted: Adrenal Tumors; Adrenocortical Carcinoma; Cushing Syndrome; Conn Syndrome; Pheochromocytoma
Phase: N/A
Status: Recruiting
Sponsored by: University of Wuerzburg Official(s) and/or principal investigator(s): Martin Fassnacht, MD, Principal Investigator, Affiliation: U of Wuerzburg
Overall contact: Martin Fassnacht, MD, Phone: 49-931-201-36507, Email: fassnacht_m@medizin.uni-wuerzburg.de
Summary
The pathogenesis of adrenal tumors is still not fully elucidated and the treatment options
for malignant tumors are poor. The current study investigates different aspects of the
pathogenesis of adrenal tumors and evaluates different therapeutic options in patients with
adrenocortical carcinoma.
Clinical Details
Official title: Investigation of the Tumorigenesis of Adrenal Tumors and Evaluation of New Therapeutic Options - Untersuchungen Zur Tumorgenese Von Nebennierentumoren Und Evaluation Neuer Therapieoptionen
Study design: Observational Model: Case Control
Eligibility
Minimum age: N/A.
Maximum age: N/A.
Gender(s): Both.
Criteria:
Inclusion Criteria:
- adrenal tumor detected by imaging
Exclusion Criteria:
Locations and Contacts
Martin Fassnacht, MD, Phone: 49-931-201-36507, Email: fassnacht_m@medizin.uni-wuerzburg.de
University of Wuerzburg, Wuerzburg 97080, Germany; Recruiting Martin Fassnacht, MD, Email: fassnacht_m@medizin.uni-wuerzburg.de Stefanie Hahner, MD, Email: hahner_s@medizin.uni-wuerzburg.de Martin Fassnacht, MD, Principal Investigator
Additional Information
Starting date: September 2002
Last updated: July 6, 2010
|